Executive Medical Director, Penn Medicine Ann B. Barshingr Cancer Institute. Lancaster General Health
Philadelphia
Joined November 2013
- Tweets416
- Following232
- Followers698
- Likes1.1K
Efrat Dotan MD retweeted
Rest in peace dear Rachna. 💔 cancercenter.arizona.edu/new…
Standing ovation for Daraxonrasib data! Amazing advancements for pancreatic cancer patients. #ASCO26.
Efrat Dotan MD retweeted
#ClinicalTrial EA6244, led by @YanaNajjarMD of @UPMCHillmanCC, is testing a less invasive treatment approach for older adults with early-stage #melanoma. Learn more: bit.ly/ea6244-study
Efrat Dotan MD retweeted
A new study reveals FOLFIRINOX is feasible for select elderly patients w/ pancreatic cancer. In an accompanying editorial, @ramsedhom & @efratdotan emphasized the study adds critical insights on the “tension between efficacy and tolerability.” @TargetedOnc spr.ly/6017hDOd9
Efrat Dotan MD retweeted
📌NALIRIFOX vs Gem-nabpaclitaxel in >70 y patients
subgroup analysis of NAPOLI 3 @ESMO_Open @myESMO
✅Benefit sustained
✅No signal for increased toxicity
👉esmoopen.com/article/S2059-7…
#cancer #omcology #MedX #pancreatic @OncoAlert @realbowtiedoc
Efrat Dotan MD retweeted
Imagine 4 new anticancer drugs Pallituzumab, Geriatriximab, Symptomab, & Exercizumab hit the market. They should dominate the plenary sessions at ASCO & command billion-dollar revenue. But they don't because they're nonpharmacologic & shame on us.
Read our opinion piece in @JCO_ASCO
ascopubs.org/doi/full/10.120…
Efrat Dotan MD retweeted
@efratdotan & I in @JCOOP_ASCO on pancreatic cancer in older adults ascopubs.org/doi/10.1200/OP-…
1. PDAC needs a systems approach of evaluating fitness for older adults. We make the analogy that Edison's light bulb is useless without durable filaments, sockets, electric grids
Efrat Dotan MD retweeted
Do you have advanced non-small cell #LungCancer and are age 70 or older? If so, you may be able to participate in this study of a new treatment approach. Learn more: bit.ly/ea5221-achieve cc: @BalazsHalmosMD, @efratdotan, @CPresGeriOncMD
Efrat Dotan MD retweeted
Voting for ASCO Election closes Mon, Dec 8 @ 3PM ET! I am honored to be running as one of the candidates for the Nominating Committee. Visit asco.org/election to learn more and vote!
Efrat Dotan MD retweeted
A new study shows that elevated early-onset cancer incidence is accompanied by similar increases in older adults. The increase is “not restricted to young adults but affects all generations," noted @LGHealth’s @efratdotan in an editorial. spr.ly/6019Ah0HL
Efrat Dotan MD retweeted
PC3I & @PennCancer announce the creation a hub to address the needs of older adults w/ #cancer: The Center for Cancer & Aging.
Led by @efratdotan & @ramsedhom, the Center will focus on integrating patient-centered #geriatric principles into #cancercare.
pc3i.upenn.edu/news/penn-med…
Efrat Dotan MD retweeted
Congrats @NVijayvergiaMD on being awarded the 2025 @NANETS1 Distinguished Clinician Award. You’re truly a leader in our field and such a big inspiration for so many like me. Thanks for your phenomenal and impactful work; this is such a well-deserved honor. @PamelaKunzMD @FoxChaseCancer
Efrat Dotan MD retweeted
Do you have advanced non-small cell #LungCancer and are age 70 or older? If so, you may be able to participate in this study of a new treatment approach. Learn more: bit.ly/ea5221-achieve cc: @BalazsHalmosMD, @efratdotan, @CPresGeriOncMD
Efrat Dotan MD retweeted
Excited to team up with @efratdotan in our new Center for Cancer & Aging @PennMedicine @PC3Innovation
We welcome collaboration from industry, start-ups, & academia to improve the care of older adults with cancer
pc3i.upenn.edu/our-work/pc3i…
Efrat Dotan MD retweeted
Congratulations Neena and @FoxChaseCancer ! 👏🏽👏🏽👏🏽@NVijayvergiaMD
Time to celebrate 🤩 @NVijayvergiaMD! She’s the new #GI Section Leader of @FoxChaseCancer 👏👏. I am sure she’s going do a FANTASTIC job!!!! I am SO proud of her!!!! CONGRATULATIONS 🎉🍾🎈🎊!!!! @ChrisCannMD #cancer #cancerresearch @eaonc
Efrat Dotan MD retweeted
Such a well deserved standing ovation for Chris Booth and the Challenge trial. These data are quite powerful. Much stronger evidence than what we saw in plenaries today. #ASCO25
New standard of care for stage III, improved DFS with the addition of atezolizumab to FOLfOX. Yet, many questions remain regarding the length of therapy and possible use of immunotherapy alone. #ASCO2025
Inspiring presentation by @HKlepinMD on her journey in geriatric oncology. Congratulations for well deserved winner of the geriatric oncology ASCO award. #ASCO2025
Efrat Dotan MD retweeted
Thrilled to share that our team @PennMedicine @PrincetonHealth has received the 2025 @ACCCBuzz Innovator Award for Geriatric Oncology Program! accc-cancer.org/home/about/a…
Older adults deserve care tailored to their needs—and we made it real! and scalable @PC3Innovation
Efrat Dotan MD retweeted
Thank you @6abc for increasing awareness of the alarming rise of young adult cancers and for highlighting our program at @FoxChaseCancer designed to optimize the care of this underrepresented patient population 6abc.com/post/young-adult-ca…
